330 related articles for article (PubMed ID: 15536921)
1. Trade agreements, intellectual property, and the role of the World Bank in improving access to medicines in developing countries.
Rovira J
Yale J Health Policy Law Ethics; 2004; 4(2):401-13. PubMed ID: 15536921
[No Abstract] [Full Text] [Related]
2. Implications of bilateral free trade agreements on access to medicines.
Correa CM
Bull World Health Organ; 2006 May; 84(5):399-404. PubMed ID: 16710551
[TBL] [Abstract][Full Text] [Related]
3. Has the implementation of the TRIPS Agreement in Latin America and the Caribbean produced intellectual property legislation that favours public health?
Oliveira MA; Bermudez JA; Chaves GC; Velásquez G
Bull World Health Organ; 2004 Nov; 82(11):815-21. PubMed ID: 15640916
[TBL] [Abstract][Full Text] [Related]
4. A trade agreement's impact on access to generic drugs.
Shaffer ER; Brenner JE
Health Aff (Millwood); 2009; 28(5):w957-68. PubMed ID: 19706626
[TBL] [Abstract][Full Text] [Related]
5. TRIPS, pharmaceutical patents, and access to essential medicines: a long way from Seattle to Doha.
't Hoen E
Chic J Int Law; 2002; 3(1):27-46. PubMed ID: 15709298
[No Abstract] [Full Text] [Related]
6. Essential drugs in the new international economic environment.
Velásquez G; Boulet P
Bull World Health Organ; 1999; 77(3):288-92. PubMed ID: 10212525
[TBL] [Abstract][Full Text] [Related]
7. A one-time-only combination: Emergency medicine exports and the TRIPS agreement under Canada's access to medicines regime.
Weber A; Mills L
Health Hum Rights; 2010 Jun; 12(1):109-22. PubMed ID: 20930258
[TBL] [Abstract][Full Text] [Related]
8. Addressing legal and political barriers to global pharmaceutical access: options for remedying the impact of the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) and the imposition of TRIPS-plus standards.
Cohen-Kohler JC; Forman L; Lipkus N
Health Econ Policy Law; 2008 Jul; 3(Pt 3):229-56. PubMed ID: 18634618
[TBL] [Abstract][Full Text] [Related]
9. Deadlock on access to cheap drugs at global trade negotiations.
Hagmann M
Bull World Health Organ; 2003; 81(2):150-1. PubMed ID: 12751424
[No Abstract] [Full Text] [Related]
10. The GO License: only part of the solution.
Batson A; Milstien JB
Health Aff (Millwood); 2008; 27(1):140-2. PubMed ID: 18180489
[TBL] [Abstract][Full Text] [Related]
11. GATT and the gap: how to save lives.
James JS
AIDS Treat News; 1998 Nov; (No 307):1, 3-6. PubMed ID: 11366123
[TBL] [Abstract][Full Text] [Related]
12. Patent necessity: intellectual property dilemmas in the biotech domain and treatment equity for developing countries.
Spectar JM
Houst J Int Law; 2002; 24(2):227-78. PubMed ID: 16189914
[No Abstract] [Full Text] [Related]
13. Health and intellectual property rights.
Correa CM
Bull World Health Organ; 2001; 79(5):381. PubMed ID: 11417031
[No Abstract] [Full Text] [Related]
14. The right to health and medicines: the case of recent multilateral negotiations on public health, innovation and intellectual property.
Velasquez G
Dev World Bioeth; 2014 Aug; 14(2):67-74. PubMed ID: 24813066
[TBL] [Abstract][Full Text] [Related]
15. [Essential medicines and the TRIPS Agreement: collision between the right to health and intellectual property rights].
Allard Soto R
Salud Colect; 2015 Mar; 11(1):9-21. PubMed ID: 25853827
[TBL] [Abstract][Full Text] [Related]
16. Africa, access, and patents: moving fast.
James JS
AIDS Treat News; 1999 Jul; (No 322):5-8. PubMed ID: 11366567
[TBL] [Abstract][Full Text] [Related]
17. What is the impact of intellectual property rules on access to medicines? A systematic review.
Tenni B; Moir HVJ; Townsend B; Kilic B; Farrell AM; Keegel T; Gleeson D
Global Health; 2022 Apr; 18(1):40. PubMed ID: 35428250
[TBL] [Abstract][Full Text] [Related]
18. Affordable antiretroviral drugs for the under-served markets: how to expand equitable access against the backdrop of challenging scenarios?
Dionisio D; Cao Y; Hongzhou L; Kraisintu K; Messeri D
Curr HIV Res; 2006 Jan; 4(1):3-20. PubMed ID: 16454707
[TBL] [Abstract][Full Text] [Related]
19. Access to generic antiretrovirals: inequality, intellectual property law, and international trade agreements.
Castro A; Westerhaus M
Cad Saude Publica; 2007; 23 Suppl 1():S85-96. PubMed ID: 17308722
[TBL] [Abstract][Full Text] [Related]
20. Harmonization, regulation, and trade: interactions in the pharmaceutical field.
Timmermans K
Int J Health Serv; 2004; 34(4):651-61. PubMed ID: 15560428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]